Literature DB >> 3502117

C-kinase activity in normal B cells treated with Staphylococcus aureus, Cowan strain I, and phorbol ester: response differences in a patient with prolymphocytic leukaemia.

R Cooper1, J Louw, J Daniels, D P de Beer, A E Nel.   

Abstract

Ca+2/phospholipid-dependent kinase (C-kinase) activity is intimately involved with the B-cell response after ligation of its mIg receptor. Here, we extend previous findings with anti-mIg by showing that polyclonal stimulation with Staphylococcus aureus, Cowan strain I (SAC), could also translocate C-kinase from the cytosol of intact, normal human B lymphocytes. This stimulus could not, however, induce redistribution of enzyme in a prolymphocytic leukaemia (PLL) B-cell population. Despite a normal density of mIg receptors on the latter cell type, PPL cells could not be stimulated to proliferate, express interleukin-2 (IL-2) receptors, and differentiate under the influence of SAC, even in the presence of exogenous IL-2. Normal B cells could respond appropriately to the same stimuli. PLL cells had a normal content of C-kinase activity and the enzyme could be translocated under the influence of the specific agonist, 12-0-tetradecanoyl phorbol-13-acetate (TPA). The same agent could induce cellular proliferation and differentiation in PLL cells, showing that its terminal C-kinase dependent pathways were intact. We conclude that the mIg receptor mechanism of this PLL population could not activate C-kinase appropriately.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3502117      PMCID: PMC1453432     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  27 in total

1.  Enhancement of sheep red blood cell human lymphocyte rosette formation by the sulfhydryl compound 2-amino ethylisothiouronium bromide.

Authors:  M A Pellegrino; S Ferrone; M P Dierich; R A Reisfeld
Journal:  Clin Immunol Immunopathol       Date:  1975-01

Review 2.  Differentiation capacity and other properties of the leukemic cells of chronic lymphocytic leukemia.

Authors:  S M Fu; N Chiorazzi; H G Kunkel
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

3.  Prolymphocytic leukaemia.

Authors:  D A Galton; J M Goldman; E Wiltshaw; D Catovsky; K Henry; G J Goldenberg
Journal:  Br J Haematol       Date:  1974-05       Impact factor: 6.998

4.  Separate signals for human B cell proliferation and differentiation in response to Staphylococcus aureus: evidence for a two-signal model of B cell activation.

Authors:  R J Falkoff; L P Zhu; A S Fauci
Journal:  J Immunol       Date:  1982-07       Impact factor: 5.422

5.  Human lymphocyte surface immunoglobulin capping. Normal characteristics and anomalous behavior of chronic lymphocytic leukemic lymphocytes.

Authors:  H J Cohen
Journal:  J Clin Invest       Date:  1975-01       Impact factor: 14.808

6.  Polyspecificity of monoclonal lupus autoantibodies produced by human-human hybridomas.

Authors:  Y Shoenfeld; J Rauch; H Massicotte; S K Datta; J André-Schwartz; B D Stollar; R S Schwartz
Journal:  N Engl J Med       Date:  1983-02-24       Impact factor: 91.245

7.  Direct activation of calcium-activated, phospholipid-dependent protein kinase by tumor-promoting phorbol esters.

Authors:  M Castagna; Y Takai; K Kaibuchi; K Sano; U Kikkawa; Y Nishizuka
Journal:  J Biol Chem       Date:  1982-07-10       Impact factor: 5.157

8.  B-lineage prolymphocytic leukemia as a distinct clinicopathologic entity.

Authors:  I Katayama; M Aiba; L Pechet; J L Sullivan; P Roberts; R E Humphreys
Journal:  Am J Pathol       Date:  1980-05       Impact factor: 4.307

9.  Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells.

Authors:  T H Tötterman; K Nilsson; C Sundström
Journal:  Nature       Date:  1980-11-13       Impact factor: 49.962

10.  Anti-immunoglobulin, cytoplasmic free calcium, and capping in B lymphocytes.

Authors:  T Pozzan; P Arslan; R Y Tsien; T J Rink
Journal:  J Cell Biol       Date:  1982-08       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.